期刊
EMERGING INFECTIOUS DISEASES
卷 28, 期 7, 页码 1530-1533出版社
CENTERS DISEASE CONTROL & PREVENTION
DOI: 10.3201/eid2807.220198
关键词
-
资金
- Medical Research Future Fund [MRF9200006]
The widespread use of corticosteroids for COVID-19 treatment has resulted in the reactivation of Strongyloides and the occurrence of severe disease in patients from endemic areas. We report a case of a US patient with COVID-19 and Strongyloides hyperinfection syndrome, and review other reported cases. Our findings emphasize the importance of Strongyloides screening and treatment in high-risk populations.
Widespread use of corticosteroids for COVID-19 treatment has led to Strongyloides reactivation and severe disease in patients from endemic areas. We describe a US patient with COVID-19 and Strongyloides hyperinfection syndrome and review other reported cases. Our findings highlight the need for Strongyloides screening and treatment in high-risk populations.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据